REGISTERED OFFICE

GRANULES INDIA LTD., 2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad - 500 081, Telangana, INDIA.

Tel: +91 40 69043500, Fax: +91 40 23115145, mail@granulesindia.com, www.granulesindia.com

CIN: L24110TG1991PLC012471

`

Dated August 26, 2022

To,

National Stock Exchange of India Limited

BSE Limited

Symbol: NSE: GRANULES; BSE: 532482

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sub: Update on GPI facility

Dear Sir,

This is with respect to our communication dated July 23, 2022, regarding the US FDA inspection of Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, USA and issuance of Form 483 with 6 observations.

We now wish to inform you that the GPI has received a communication from the US FDA indicating the inspection classification as "Voluntary Action Indicated." (VAI). The VAI inspection classification indicates that the US FDA will not take or recommend regulatory or enforcement action because the observations do not meet the threshold for action at this time.

This is for your information and dissemination to the members of the exchange.

Thanking You.

Yours sincerely,

For GRANULES INDIA LIMITED

CHAITANYA TUMMALA

Digitally signed by CHAITANYA TUMMALA DN: c=IN, o=PERSONAL, title=1722, pseudonym=5a1421da00444714ae97e8764 0a0419e, 2.5.4.20=f7feec72a52be0b16d0827d9d73aa 615bad9538180242f5bb3efe11f1a5fd10d, postalCode=500013, st=TELANGANA, serialNumber=ae6c5085a4c307805711d3f1 ab8a1ff2da48346a26aa5fe898e52ec0775c3c 69, cn=CHAITANYA TUMMALA

Date: 2022.08.26 08:02:29 +05'30'

CHAITANYA TUMMALA (COMPANY SECRETARY & COMPLIANCE OFFICER)

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Granules India Limited published this content on 26 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 August 2022 12:00:03 UTC.